On July 21, 2026, Dr. Soliman Abdel Kader Fakeeh Hospital Co. announced the completion of its acquisition of 100% of the share capital of Dr. Mohammed Bin Rashid Al Fagih & Partners Company, with the transaction finalized on July 20, 2026. The total cash consideration amounted to SAR 1,595,625,000, of which SAR 100 million has been placed in an escrow account to cover potential post-completion liabilities. The Target Company, which operates a 350-bed hospital, becomes the Company's second facility in Riyadh and will be consolidated as a wholly-owned subsidiary, expanding the group's total Riyadh bed capacity to 535 beds across two sites. The acquisition is expected to diversify the Company's payer and patient mix, generate operational efficiencies and cost synergies, while also increasing the Company's consolidated debt levels due to acquisition financing and the assumption of the Target Company's existing net debt.

Original announcement:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.